Increased Risk of Death for HIV+ People Mostly Due to Modifiable Risk Factors
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Wednesday, 17 August 2011 00:00
- Written by Liz Highleyman
Elevated mortality among people with HIV is largely attributable to risk factors that are modifiable before or during antiretroviral therapy (ART), according to the latest findings from the Danish HIV cohort published in the July 25, 2011, online edition of PLoS Medicine.
IAS 2011: HIV Treatment In Primary Infection: 48 Week Course Modestly Delays CD4 Drop
- Details
- Category: Primary/Acute HIV
- Published on Friday, 12 August 2011 00:00
- Written by Keith Alcorn
A 48-week course of antiretroviral treatment started within six months of becoming infected modestly delays the need for lifelong treatment, reported Sarah Fidler of Imperial College, London, at the 6th International AIDS Society Conference (IAS 2011) in Rome.
IAS 2011: Anti-Herpes Drugs Reduce HIV Viral Load, Slow Disease Progression
- Details
- Category: HIV Disease Progression
- Published on Tuesday, 02 August 2011 00:00
- Written by Liz Highleyman
Several studies presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) last month in Rome showed that treating herpes simplex virus type 2 (HSV-2) with acyclovir or valacyclovir (Valtrex) reduced HIV viral load and slowed disease progression.

IAS 2011: Poor CD4 Cell Recovery after Starting HIV Treatment Should Be a Cause For Concern
- Details
- Category: HIV Disease Progression
- Published on Tuesday, 09 August 2011 00:00
- Written by Michael Carter
Patients whose CD4 cell count does not recover despite achieving virologic control with HIV therapy require continued medical attention, results of a large European study presented to the recent International AIDS Society conference (IAS 2011) in Rome show.
Can Cannabis Reduce HIV Disease Progression?
- Details
- Category: Alternative & Complementary Therapy
- Published on Tuesday, 31 May 2011 03:10
- Written by Liz Highleyman
THC, the main psychoactive component in marijuana, was associated with decreased viral load and lower risk of death in monkeys infected with a virus related to HIV. 
HIV/AIDS Topics 















